BACKGROUND: Pregnancy-related cardiovascular conditions are associated with both poorer pregnancy outcomes and cardiovascular disease later in life. Little is known about the relationship between preconception cardiovascular risk factor levels and pregnancy complications. METHODS: Data from the Cardiovascular Risk in Young Finns Study were linked with birth registry data for 1142 primiparous women. Age-standardized levels of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, blood pressure, insulin, and glucose from the study visit prior to last menstrual period were calculated. These factors were examined as predictors of gestational age, preterm birth (<37 weeks), birthweight, low birthweight (<2500 g), small-for-gestational-age (weight <10th percentile for gestational age), hypertensive disorders of pregnancy, and gestational diabetes, using linear and Poisson regression with adjustment for age, body mass index, smoking, and socioeconomic status. RESULTS: Higher triglycerides were associated with a higher risk of hypertensive disorders (adjusted risk ratio [aRR] = 1.42 [95% confidence interval (CI) = 0.90-2.23]), preeclampsia (1.70 [1.08-2.65]), and gestational diabetes (1.68 [1.25-2.25]). After removing women with pregnancy complications (n = 30), the estimated aRR for the association between systolic blood pressure and preterm birth was 1.23 (95% CI = 0.99-1.54); for HDL-c and low birthweight, 0.97 (0.73-1.28); for diastolic blood pressure and small-for-gestational-age, 0.98 (0.81-1.20); and for systolic blood pressure and small-for-gestational-age, 1.18 (0.97-1.45). CONCLUSIONS: High lipid levels before pregnancy predict an increased risk of preeclampsia and gestational diabetes. Reported associations between these pregnancy complications and later cardiovascular disease of the mother are probably explained, at least in part, by maternal conditions that precede pregnancy. Interventions to improve cardiovascular health before pregnancy may reduce risk of pregnancy complications.
BACKGROUND: Pregnancy-related cardiovascular conditions are associated with both poorer pregnancy outcomes and cardiovascular disease later in life. Little is known about the relationship between preconception cardiovascular risk factor levels and pregnancy complications. METHODS: Data from the Cardiovascular Risk in Young Finns Study were linked with birth registry data for 1142 primiparous women. Age-standardized levels of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, blood pressure, insulin, and glucose from the study visit prior to last menstrual period were calculated. These factors were examined as predictors of gestational age, preterm birth (<37 weeks), birthweight, low birthweight (<2500 g), small-for-gestational-age (weight <10th percentile for gestational age), hypertensive disorders of pregnancy, and gestational diabetes, using linear and Poisson regression with adjustment for age, body mass index, smoking, and socioeconomic status. RESULTS: Higher triglycerides were associated with a higher risk of hypertensive disorders (adjusted risk ratio [aRR] = 1.42 [95% confidence interval (CI) = 0.90-2.23]), preeclampsia (1.70 [1.08-2.65]), and gestational diabetes (1.68 [1.25-2.25]). After removing women with pregnancy complications (n = 30), the estimated aRR for the association between systolic blood pressure and preterm birth was 1.23 (95% CI = 0.99-1.54); for HDL-c and low birthweight, 0.97 (0.73-1.28); for diastolic blood pressure and small-for-gestational-age, 0.98 (0.81-1.20); and for systolic blood pressure and small-for-gestational-age, 1.18 (0.97-1.45). CONCLUSIONS: High lipid levels before pregnancy predict an increased risk of preeclampsia and gestational diabetes. Reported associations between these pregnancy complications and later cardiovascular disease of the mother are probably explained, at least in part, by maternal conditions that precede pregnancy. Interventions to improve cardiovascular health before pregnancy may reduce risk of pregnancy complications.
Authors: Janet M Catov; Roberta B Ness; Melissa F Wellons; David R Jacobs; James M Roberts; Erica P Gunderson Journal: J Clin Endocrinol Metab Date: 2010-05-25 Impact factor: 5.958
Authors: Christine D Odell; Milton Kotelchuck; V K Chetty; Josephine Fowler; Phillip G Stubblefield; Malena Orejuela; Brian W Jack Journal: Matern Child Health J Date: 2006-01
Authors: K V Porkka; O T Raitakari; A Leino; S Laitinen; L Räsänen; T Rönnemaa; J Marniemi; T Lehtimäki; S Taimela; M Dahl; M Uhari; H K Akerblom; J S Viikari Journal: Am J Epidemiol Date: 1997-07-01 Impact factor: 4.897
Authors: Janet M Catov; Anne B Newman; James M Roberts; Kim C Sutton-Tyrrell; Sheryl F Kelsey; Tamara Harris; Rebecca Jackson; Lisa H Colbert; Suzanne Satterfield; Hilsa N Ayonayon; Roberta B Ness Journal: Ann Epidemiol Date: 2006-07-12 Impact factor: 3.797
Authors: Brietta M Oaks; Christine P Stewart; Kevin D Laugero; Seth Adu-Afarwuah; Anna Lartey; Stephen A Vosti; Per Ashorn; Kathryn G Dewey Journal: Matern Child Nutr Date: 2016-12-27 Impact factor: 3.092
Authors: Emily W Harville; Markus Juonala; Jorma S A Viikari; Mika Kähönen; Olli T Raitakari Journal: Hypertens Pregnancy Date: 2016-11-18 Impact factor: 2.108
Authors: Jerad H Dumolt; Min Ma; Joyce Mathew; Mulchand S Patel; Todd C Rideout Journal: Am J Physiol Endocrinol Metab Date: 2019-08-27 Impact factor: 4.310
Authors: Carrie J Nobles; Pauline Mendola; Sunni L Mumford; Robert M Silver; Keewan Kim; Victoria C Andriessen; Matthew Connell; Lindsey Sjaarda; Neil J Perkins; Enrique F Schisterman Journal: Hypertension Date: 2020-08-03 Impact factor: 10.190